Welcome to our dedicated page for Dupont De Nemours SEC filings (Ticker: DD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
DuPont de Nemours, Inc. filings document the regulatory disclosures of a Delaware specialty materials company with common stock listed on the New York Stock Exchange under DD. Its 8-K reports cover operating and financial results, Regulation FD disclosures, material events, board composition changes, corporate-governance matters and capital-structure disclosures.
DuPont proxy materials describe annual stockholder voting matters, director elections, governance practices, executive compensation and proposals affecting the company’s certificate of incorporation and common stock. Recent filings also document separation-related matters, including disclosures connected with the completed Qnity Electronics spin-off, as well as agreements and percentage calculations tied to the post-separation corporate structure.
DuPont de Nemours, Inc. reports that it expects to close the previously announced sale of its aramids business, which includes the Kevlar and Nomex product lines, to Arclin on April 1, 2026. All regulatory conditions required to complete the sale were satisfied as of March 10, 2026.
The company notes that statements about the timing and completion of the transaction are forward-looking and subject to various risks, including potential closing conditions, separation impacts and the future performance of the Arclin entity in which DuPont expects to hold a minority interest.
DuPont de Nemours, Inc. director Alexander M. Cutler reported an automatic acquisition of common stock. On 2026-02-27, he received 999.2006 shares at $50.04 per share as a grant or similar award, including dividend reinvestment, increasing his direct holdings to 76,609.0025 shares.
DuPont de Nemours, Inc. director Frederick M. Lowery reported an acquisition of common stock through an award. On this Form 4, he received 774.3804 shares of DuPont common stock at a reported price of $50.04 per share, increasing his directly held stake to 35,290.2764 shares. The filing notes that this total includes shares acquired through dividend reinvestment.
DuPont de Nemours, Inc. director Donald G. Macpherson reported an acquisition of common stock through a grant or award. He received 216.4934 shares of DuPont common stock at a reference price of $50.04 per share, bringing his directly owned stake to 1,162.4934 shares.
DuPont de Nemours, Inc. director Donald G. Macpherson reported the acquisition of 946 shares of common stock through a grant or award. The shares were recorded at a price of $0.00 per share, indicating they were awarded rather than purchased on the open market. Following this transaction, he directly holds 946 common shares of DuPont de Nemours. The filing notes that the transaction was reported late due to an inadvertent administrative error.
DuPont de Nemours SVP & General Counsel Erik T. Hoover reported two stock transactions. He received a grant of 11,903 shares of common stock at no cost, then had 2,583 shares withheld at $50.36 per share to cover taxes on lapsed RSUs and related dividend equivalents.
DuPont de Nemours, Inc. executive Jeroen Bloemhard reported two equity transactions in company stock. On February 20, 2026, he acquired 9,919 shares of common stock as a grant or award at $0.00 per share, increasing his direct holdings.
On February 21, 2026, 1,028 shares were disposed of at $50.36 per share to cover tax withholding on lapsed RSUs and related dividend equivalent units, according to the footnote. After these transactions, he directly owned 24,770.0519 shares of DuPont common stock.
DuPont de Nemours, Inc. SVP & CFO Antonella B. Franzen reported two stock transactions. On February 20, she acquired 19,838 shares of common stock as a grant or award at $0 per share, increasing her direct holdings. On February 21, 1,631 shares were disposed of at $50.36 per share to satisfy tax withholding on lapsed RSUs and related dividend equivalents, leaving her with 70,360.5346 shares directly owned.
Ferreira Beth reported acquisition or exercise transactions in this Form 4 filing.
DuPont de Nemours, Inc. executive Beth Ferreira, President of Diversified Industrial, received a grant of 9,919 shares of common stock on February 20, 2026. The award was recorded at $0.00 per share, indicating it was an equity grant rather than an open-market purchase. After this grant, her directly owned stake increased to 20,569.3291 shares of DuPont common stock.
DuPont de Nemours, Inc. director and CEO Lori Koch reported two equity-related transactions in company common stock. On February 20, 2026, she received a grant of 79,350 shares of common stock at $0.00 per share as a stock award, increasing her direct holdings.
On February 21, 2026, 8,123 shares at $50.36 per share were disposed of in a tax-withholding transaction, with the footnote stating these shares covered taxes on lapsed RSUs and related dividend equivalent units. After this withholding, Koch directly owned 351,849.6031 shares of DuPont common stock.